8-119732159-C-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The ENST00000378164.7(TAF2):c.3365G>A(p.Ser1122Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0691 in 1,613,680 control chromosomes in the GnomAD database, including 5,010 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000378164.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF2 | NM_003184.4 | c.3365G>A | p.Ser1122Asn | missense_variant | 26/26 | ENST00000378164.7 | NP_003175.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF2 | ENST00000378164.7 | c.3365G>A | p.Ser1122Asn | missense_variant | 26/26 | 1 | NM_003184.4 | ENSP00000367406 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0976 AC: 14838AN: 152078Hom.: 1089 Cov.: 33
GnomAD3 exomes AF: 0.0619 AC: 15569AN: 251316Hom.: 797 AF XY: 0.0590 AC XY: 8007AN XY: 135820
GnomAD4 exome AF: 0.0661 AC: 96625AN: 1461484Hom.: 3921 Cov.: 32 AF XY: 0.0650 AC XY: 47251AN XY: 727076
GnomAD4 genome AF: 0.0976 AC: 14850AN: 152196Hom.: 1089 Cov.: 33 AF XY: 0.0943 AC XY: 7021AN XY: 74422
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
TAF2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at